1. Hou JW, Wang TR, Tunnessen WW Jr. Picture of the month. Glycogen storage disease type 1a ( Von Gierke desease ) complicated by gouty arthritis and xanthomatosis. Archives of Pediatrics & Adolescent Medicine. 150(2): 219-20, 1996.
2. Hoefnagel D, Andrew ED, Mireault NG, Berndt WO. Hereditary choreoathetosis, self-multilation and hyperuricemia in young males. New Eng. J. Med. 273: 130-135, 1965.
3. Neel JV, Rakic MT, Davidson RT, Valkenburg Ha, Mikkelson WM. Studies on hyperuricemia. II. A reconsideration of the distribution of serum uric acid values in the families of Smyth, Cotterman, and Freyburg. Am J Hum Genet 17: 14-22, 1965.
4. Wyngaarden JB, Kelley WN: Gout. In, Stanbury JB, Wyngaarden JB, Fredrickson DS (eds.): The Metabolic Basis of Inherited Disease. 3rd ed., New York: McGraw-Hill, Pp.889-968, 1972.
5. Healey LA, Skeith MD, Decker JL, Bayani-Sioson PS. Hyperuricemia in Filipinos: interaction of heredity and environment. Am J Hum Genet 19: 81-85, 1967.
6. Rao DC, Laskarzewski CJ. The cincinnati Lipid Research clinic Kelly K, Glueck CJ. The Cincinnati Lipid Research Clinic Family Study: Cultural and biological determinants of plasma uric acid. Hum Genet 60: 257-261, 1982.
7. Chang FT, Chang SJ, Wu YY, Wang TN and Ko YC: Body Mass Index and Hyperuricemia Differences Children in Taiwan . Kaohs J Med Sci 11(6): 315-321, 1995.
8. Klemp P, Stansfield SA, Castle B, Robertson MC: Gout is on the Increase in New Zealand. Ann Rheum Dis 56: 22-26, 1997.
9. Roubenoff R, Klag MJ, Mead LA, Liang KY, Seidler AJ, Hochberg MC: Incidence and Risk Factors for Gout in White Men. JAMA 266(21): 3004-3007, 1991.
10. Hochberg MC, Thomas J, Thomas DJ, Mead L, Levine DM, and Klag MJ: Racial Differences in the Incidence of Gout. Arthritis Rheum 38(5): 628-632, 1995.
11. Lawrence RC, Hochberg MC, Kelsey JL, Mcduffie FC, Medsger TA Jr, Felts WR, and Shulman LE: Estimates of the Prevalence of Selected Arthritic and Musculoskeletal Diseases in the United States. J Rheumatol 16: 427-441, 1989.
12. Lally EV, Ho G Jr, Kaplan SR: The Clinical Spectrum of Gouty Arthritis in Women. Arch Intern Med 146: 2221-2225, 1986.
13. Wallace SL, Robinson H, Masi AT, Decker JL, Mc Carth KJ, Yu TF: Preliminary Criteria for the Classification of the Acute Arthritis of Primary Gout. Arthritis Rheum 20: 895-900, 1977.
14. Dieppe PA: Investigation and Management of Gout in the Young and the Elderly. Ann Rheum Dis 50: 263-266, 1991.
15. Puig JG, Michan AD, Jimenez ML, Perez C, Mateos FA, Capitan CF, Gijon JB: Female Gout. Clinical Spectrum and Uric Acid Metabolism. Arch Intern Med 151: 726-732, 1991.
16. Fam AG, Stein J, and Rubenstein J: Gouty Arthritis in Noda Osteoarthritis. J Rheumatol 23: 684-689, 1996.
17. 賴守志，朱有仁，郭濟芳，車參莉，吳盧稔：宜蘭縣東澳里及東岳村高尿酸血症調查。疫情報導第七菤第十期，中華民國八十年。18. Macfarlane D, Dieppe P: Changing Pattern of Hospital Gout. Ann Rheum Dis 42: 219,1983.
19. Nishioka N, Mikanagi K: Clinical Features of 4000 Gouty Subjects in Japan. Adv Exp Med Biol 122A: 47-54, 1980.
20. Koh WH, Seah A, Chai P: Clinical Presentation and Disease Associations of Gout: A Hospital-based Study of 100 Patients in Singapore. Ann Acad Med Singapore 27: 7-10, 1998.
21. Brochner-Mortensen. Heberden Oration. Gout. Ann Rheum Dis 17: 1-8, 1958.
22. Drum DE, Goldman PA, Jankowski CB: Elevation of Serum Uric Acid as a Clue to Alcohol Abuse. Arch Intern Med 141: 477-9, 1981.
23. Lieber CS: Hyperuricemia Induced by Alchol. Arthritis Rheuma 8: 786-789,1965.
24. Colin R. Sharpe: A Case-control Study of Alcohol Consumption and Drinking Behavior in Patients with Acute Gout. Can Med Assoc J131: 563-567, 1984.
25. Faller J, Fox IH: Evidence of Increased Urate Production by Activation of Adenine Nucleotide Turnover. N Engl J Med 307: 1598-602,1982.
26. Seegmiller JE, Rosenbloom FM, Kelley WN: Enzyme defect associated with a sex-linked human neurological disorder and excessive purine sythesis. Science 155: 1682-4, 1967.
27. Lesch M, Nyhan WL: A familial disorder of uric acid metabolism and central nervous system function. Am J Med 36: 561-70, 1964.
28. Kelley WN, RosenBloom FM, Henderson JF, Seegmiller JE: A specific enzyme defect in gout associated with overproduction of uric acid. Proc Natl Acad Sci USA 57: 1735-9, 1967.
29. Edwards A, Voss H, Rice P, Civitello A, Stegemann J, Schwager C, Zimmermann J, Ergle H, Caskey CT, Ansorge W. Automated DNA sequencing of the Human HPRT locus. Genomics 6: 593-608, 1990.
30. Pantel PI, Framson PE, Caskey CT, Chinault AC: Use of selective media for distinguishing variant forms of hypoxanthine phosphoribosyltransferase. Clin Chem Acta 154: 195-202, 1986.
31. Jolly DJ, Okayama H, Berg P, Estu AS, Filpula D, Bohlen P, Johnson GG, Shively JE, Hunkapillar T, Friedmann T. Isolation and characterization of a full-length expressible cDNA for human hypoxanthine phosphoribosyl transferase. Proc Natl Acad Sci USA 80: 477-81, 1983.
32. Akiko Saeki, Tatsuo Hosoya, Hideaki Okabe, Masakatsu Saji, Akira Tabe, Kimioshi Ichida, Keigo Itoh, Kensuke Joh, Osamu Sakai: Newly Discovered Familial Juvenile Gouty Nephropathy in a Japanese Family. Nephron 70: 359-366, 1995.
33. Chang SJ. Chang JG. Chen CJ. Wang JC. Ou TT. Chang KL. Ko YC. Identification of a new single nucleotide substitution on the hypoxanthine-guanine phosphoribosyltransferase gene (HPRT(Tsou) from a Taiwanese aboriginal family with severe gout. Journal of Rheumatology 26(8): 1802-7, 1999.
34. Bernstein J, Gardner KD Jr: Hereditary tubulo-interstitial nephropathies. In cotran RS, Brenner BM, Stein JH(eds): “Contemporary Issues in Nephrology.” New York: Churchill Livingstone Publishers pp 335-357, 1983.
35. Kleinknecht C: The inheritance of nephronophthisis. In Spitzer A, Avner ED (eds): “Inheritance of Kidney and Urinary Tract Diseases.” Kluwer Academic Publishers pp 277-292, 1990.
36. Elston RC, Namboodiri KK, Glueck CJ, Fallat R, Tsang R, Leuba V. Study of the genetic transmission of hypercholestrolemia and hypertriglyceridemia in a 195 member kindred. Ann Hum Genet 39:67-87, 1975.
37. MacLean CJ, Morton NE, Lew R. Analysis of family resemblance, IV. Operational characteristics of segregation analysis. Am J Hum Genet 27: 365-384, 1975.
38. Demenais F, Lathrop M, Lalouel JM. Robustness and power of the unified model in the analysis of quantitative measurements. Am J Hum Genet 38: 228-234, 1986.
39. Bonney GE. Regressive logistic models for familial disease and other binary traits. Biometrics 42: 611-625, 1986.
40. Elston RC, george VT. Age of onset, age at examination and other covariates in the analysis of family data. Genet Epidemiol 6: 217-220, 1989.
41. Elston RC. Segregation analysis. Adv Hum Genet 11:63-120, 1981.
42. Go RCP, Elston RC, Kaplan EB. Efficiency and robustness of pedigree segregation analysis. Am J Hum Genet 30:37-38, 1978.
43. Go RCP, King MC, Bailey-Wilson JE, Elston RC, Lynch HT: Genetic epidemiology of breast and associated cancers in high risk families. I. Segregation analysis. J Natl Cancer Inst 71: 455-461, 1983.
44. Akaike, H: A new look at the statistical model identification. IEEE Trans. Automatic Comtrol 19: 716-723, 1974.
45. Christoforos Stavrou, Alkis Pierides, Ioanna Zouvani, Kyriacos Kyriacou, Corinne Antignac, Pavlos Neophytou, Kyproula Christodoulou, C. Constantinou Deltas: Medullary Cystic Kindeny Disease With Hyperuricemia and Gout in a Large Cypriot Family: No Allelism With Nephronophthisis Type 1. American Journal of Medical Genetics 77: 149-154, 1998.
46. Thompson GR, Weiss JJ, Goldman RT, Rigg GA: Familial occurrence of hyperuricemia, gout, and medullary cystic disease. Arch Intern Med 138: 1614-1617, 1978.
47. Burke JR, Inglis JA, Craswell PW, Mitchell KR, Emmerson BT: Juvenile nephronophthisis and medullary cystic disease－the same disease (report of a large family with medullary cystic disease associated with gout and epilepsy). Clin Nephrol 18: 1-8, 1982.
48. Mongeau JG, Worthen HG: Nephronophthisis and medullary cystic diease. Am J Med 43: 345-355, 1967.
49. Gardner KD: Evolution of clinical signs in adult－onset cystic disease of the renal medulla. Ann Intern Med 74: 47-54, 1971.
50. Hildebrant F, Waldherr R, Kutt R, Barndis M: The nephronophthisis complex: Clinical and genetic aspects. Clin Investig 70: 802-808, 1992.
51. Chou CT, LAI JS. The epidemiology of hyperuricaemia and gout in Taiwan aborigines. British journal of Rheumatology 37: 258-262, 1998.
52. Woo J, Swaminathan R, cockram C, Lau E, Chan A. Association between serum uric acid and some cardiovascular risk factors in a Chinese population. Postgrad Med J 70: 486-491, 1994.
53. Gelber AC, Klag MJ, Mead LA, Thomas J, Thomas DJ, Pearson TA, Hochberg MC. Gout and risk for subsequent coronary heart disease. The Meharry-Hopkins study. Arch Intern Med 157: 1436-1440; 1997.
54. Brauer GW, Prior IA. A prospective study of gout in New Zealand Maoris. Annals of the Rheumatic Diseases 37(5): 466-72, 1978.
55. Sharpe CR. A case-control study of alcohol consumption and drinking behavior in patients with acute gout. Canadian Medical Association Journal 131(6): 563-7, 1984.
56. Meyers OL, Monteagudo FS. A comparison of gout in men and women. A 10-year experience. South African Medical Journal 70(12): 721-3, 1986.
57. Seidell JC, Bakx KC, Deurenberg P, Hoogen HJ, Hautvast JG, Stijnen T. Overweight and chronic illness─a retrospective cohort study, with a follow-up of 6-17 years, in men and women of initially 20-50 years of age. Journal of Chronic Disease 39(8): 585-93, 1986.
58. Waller PC, Ramsay LE. Predicting acute gout in diuretic-treated hypertensive patients. Journal of Human Hypertension 3(6): 457-31, 1989.
59. Yu TA, Oreskes I. Lipid studies in primary gout. The Mount Sinai Journal of Medicine 56(1): 11-16, 1989.
60. Li Y, Stamler J, Xiao zhikui, Folsom A, TAO S, Zhang H. Serum uric acid and its correlates in Chinese adult populations, urban and rural, of Beijing. International Journal of Epidemiology 26(2): 288-296.
61. Youssef P, Brama T, York H, Pickard P, Stewart P, Mcgill N. Does renal impairment protect from gout? Journal of Rheumatology 22(3): 494-6, 1995.
62. Leske MC, Chylack LT Jr, He Q, Wu SY, Schoenfeld E, Friend J, Wolfe J. Risk factors for nuclear opalescence in a longitudinal study. LSC group. Longitudinal study of cataract. American Journal of epidemiology 147(1): 36-41, 1998.
63. Tikly M, Bellingan A, Lincoln D, Russell A. Risk factors for gout: a hospital-based study in urban black south Africans. Revue Du Rhumatisme, English Edition 65(4): 225-31, 1998.
64. Gurwitz HJ, Kalish SC, Bohn RL, Glynn RJ, Monane M, Mogun H, Avorn J. Thiazid diuretics and the initiation of anti-gout therapy. J Clin Epidemiology 50(8): 953-9, 1997.
65. Abbott RD, Brand FN, Kannel WB, Castelli WP. Gout and coronary artery disease: The Framingham Study. J Clin Epidemiol 41: 237-42, 1988.
66. Campion EW, Glynn RJ, DeLabry LO. Asymptomatic hyperuricemia: risk and consequences in the Normative Aging Study. Am J Med 82: 421-6, 1987.
67. Hall AP, Barry PE, Dawber TR, McNamara PM. Epidemiology of gout and hyperuricemia. Am J Med 42: 27-37, 1967.
68. Gibson T, Waterworth R, Hatfield P, Robinson G, Bremner K. Hyperuricaemia, gout and kidney function in new Zealand maori men. British Journal of Rheumatology 23: 276-282, 1984.
69. Simmonds HA. Purine and pyrimidine disorders. Chapter 6. In: Holeon JB (ed). The inherited metabolic disease. Churchill Livingstone, Edinburgh, p215, 1987.
70. Chang SJ, Ko YC, Wang TN, Chang FT, Cinkotai FF, and Chen CJ: High Prevalence of Gout and Related Risk Factors in Taiwan’s Aborigines. J Rheumatol 24: 1364-1369, 1997.
71. Simkin PA. Uric acid excretion in patients with gout. Arthritis Rheum 22: 98-99, 1979.
72. Puing JG, Mateos FA, Jimenez ML, Conthe PG. Renal handling of uric acid in gout: Impaired tubular transport of urate not dependent on serum urate levels. Metabolism 35: 1147-1153, 1986.
73. Becker MA, Roessler BJ. Hyperuricemia and gout; in Scriver CR, Beaudet AL, Sly WS, Valle D (eds) : The Metabolic and Molecular Bases of Inherited Disease. New York, Saunders, pp1655-1677, 1995.
74. Puing JG, Mateos FA, Jimenez ML, Ramos TH. Renal excretion of hypoxanthine and xanthine in primary gout. Am J Med 85: 533-537, 1988.
75. Campbell SM. Gout: how presentation, diagnosis, and treatment differ in the elderly. Geriatrics 2079-88, 1994.
76. Cohen MG, Emmerson B. Crystal arthropathies. In: Klippel JH, Dieppe PA, eds. Rheumatology. St Louis: Mosby-Year Book, 12.1-12.16, 1994.
77. Seegmiller JE, Dixon RM, Kemp GJ, Angus PW, Mcalindon TE, Dippe P, Rajagopalan B, Radda GK. Fructose-induced aberration of metabolism in familial gout identified by 31P magnetic resonance spectroscopy. Proceedings of the National Academy of Sciences of the United States of America 87(21): 8326-30, 1990.
78. Mayes PA. Intermediary metabolism of fructose. American Journal of Clinical Nutrition 58(5 suppl): 754S-765S, 1993.
79. Emmerson BT. Drug Therapy: The Management of Gout. The New England Journal of Medicine 334(7): 445-451, 1996.
80. Chou P, Soong LN, Lin HY. Community-Based Epidemiological Study on Hyperuricemia in Pu-Li, Taiwan. J Froms Med Assoc 92(7): 597-602.
81. Patel PI, Nussbaum RL, Framson PE, Ledbetter DH, Caskey CT, Chinault AC. Organization of the HPRT gene and related sequences in the human genome. Somat Cell Mol Genet 10: 483-493, 1984.
82. Edwards A, Voss H, Rice P, Civitello A, Stegemammm J, Schwager C, Zimmermann J, Erfle H, Caskey CT, Ansorge W. Automated DNA sequencing of the human HPRT locus. Genomics 6: 593-608, 1990.
83. Adewale A, Paul D. Rheumatic Disease in African Blacks. Seminars in Arthritis and Rheumatism 24(2): 1994.
84. Bellwood P: The Austronesian dispersal and the origin of languages. Sci Am 265: 70-75, 1991.
85. Y. Friedlander, J. D. Kark, Y. Stein. Family resemblance for serum uric acid in a Jerusalem Sample of families. Hum Genet 79: 58-63, 1988.
86. Jemma BW, Lue D, Ingrid B, Larry DA, Steven Ch, Stephen SR, John HE, Donna KA, D.C. Rao, Richard HM. Segregation analysis of serum uric acid in the NHLBI Family Heart Study. Hum Genet 106: 355-359, 2000.
87. Loeb JN. The influence of temperature on the solubility of monosodium urate. Arthritis Rheum 15:189-192, 1972.
88. Spivey JR. Bronk SF. Gores GJ. Glycochenodeoxycholate-induced lethal hepatocellular injury in rat hepatocytes. Role of ATP depletion and cytosolic free calcium. Journal of Clinical Investigation 92(1):17-24, 1993.
89. Boss GR, Seegmiller JE. Hyperuricemia and gout. N Engl J Med 300: 1459-68, 1979.
90. Levinson DJ. Clinical gout and the pathogenesis of hyperuricemia. In : McCarty DJ, ed. Arthritis and allied conditions. 11th ed. Philadelphia: Lee and Febiger 1645-76, 1989.
91. Gulbrandsen CL, Morton NE, Rao DC, Rhoads GG, Kagan A. Determinants of plasma uric acid. Hum Genet 50: 307-312, 1979.
92. Rao DC, Laskarzewski PM, Morrison JA, Khoury P, Kelly K, Glueck CJ. The Cincinnati Lipid Research Clinic Family Study: Familial determinants of plasma uric acid. Hum Genet 60: 257-261, 1982.
93. Feinleib M, Garrison RJ, Fabsitz R, Christian JC, Hrubec Z, Borhan NO, Kannel WB, Rosenman R, Schwartz JR, Wagner JO. The NHLBI twin study of cardiovascular disease risk factors: Methodology and summary of results. Am J Epidemiol 106: 284-295, 1977.
94. Havlik R, Garrison R, Fabsitz R, Feineib M. Genetic variability of clinical chemical values. Clin Chem 23: 659-662, 1977.
95. Whitfield JB, Martin NG. Inheritance and alcohol as factors influencing plasma uric acid levels. Acta Genet Med Gemellol (Roma) 32: 117-126, 1983.
96. Colletto GMDD, Krieger H, Reinaldo J. Genetic and environmental determinants of 17 serum biochemical traits in Brazilian twins. Acta Genet Med Gemellol (Roma) 32: 23-29, 1983.
97. Kalousdian S, Fabsitz R, Havlik R, Christian J, Rosenman R. Heritability of clinical chemistries in an older twin cohort: The NHLBI twin study. Genet Epidemiol 4: 1-11, 1987.
98. Smyth CJ, Cotterman CW, Freyberg RH. The genetics of gout and hyperuricemia — an analysis of nineteen families. J Clin Invest 27: 749-759, 1948.
99. Stecher RM, Hersh AH, Soloman WM. The heredity of gout and its relationship to familial hyperuricemia. Ann Intern Med 31: 595-614, 1949.
100. Morton NE. Genetics of hyperuricemia in families with gout. Am J Med Genet 4: 103-106, 1979.
101. Rice T, Laskarzwski PM, Perry TS, Rao DC. Comingling and segregation analysis of serum uric acid in five North American populations: the Lipid Research Clinics Family Study. Hum Genet 60: 133-138.